These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34223879)

  • 21. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study.
    Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ
    Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK; Tan FU; Kendi T; Koc C
    J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do repetitive botulinum neurotoxin injections induce muscle fibrosis? Sonographic observation of the masseter muscle.
    Koo HJ; Hu H; Kim W; Kim JS; Kim HJ; Yi KH
    J Cosmet Dermatol; 2024 Feb; 23(2):434-440. PubMed ID: 37942679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of changes in masseter muscle by three-dimensional close-range photogrammetry after Botulinum toxin type-A injection: A case report with review of literature.
    Bayrak NB; Zeybek M; Sanlioglu I; Dolanmaz D
    J Pak Med Assoc; 2019 Mar; 69(3):418-422. PubMed ID: 30890839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary on a Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Cox SE
    Dermatol Surg; 2015 Nov; 41(11):1309. PubMed ID: 26448313
    [No Abstract]   [Full Text] [Related]  

  • 28. Uses of botulinum toxin.
    Girdler NM
    Lancet; 1997 Mar; 349(9056):953. PubMed ID: 9093271
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
    Nilesh K; Dharamsi R; Patil P; Mate P
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M; Işeri PK
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First case of anaphylaxis after botulinum toxin type A injection.
    Moon IJ; Chang SE; Kim SD
    Clin Exp Dermatol; 2017 Oct; 42(7):760-762. PubMed ID: 28639343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study.
    Jung BK; Park H; Cheon YW; Yun IS; Choi JW; Kim HJ; Lee MY; Kang BS; Kang TJ
    J Craniomaxillofac Surg; 2023 May; 51(5):332-337. PubMed ID: 37353404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
    Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of antithrombotics for intramuscular injection of botulinum toxin for spasticity. A survey of real-life practice in France.
    Ble O; Bensmail D; Pérennou D; Parratte B; Joseph PA; Boyer FC; Michelon H; Lansaman T; Levy J
    Ann Phys Rehabil Med; 2021 Nov; 64(6):101467. PubMed ID: 33316432
    [No Abstract]   [Full Text] [Related]  

  • 35. Pivotal role of injection volume on sunken cheek prevention in masseter muscle BoNT-A injection: A cadaver study.
    Yu P; Zhai H; Li Z; Dong R; Wu T; Li Y; Di Z; Sun Y; Long X; Yu N
    J Cosmet Dermatol; 2022 Jan; 21(1):137-141. PubMed ID: 34897934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness?
    Park G; Choi YC; Bae JH; Kim ST
    Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
    Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
    Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
    [No Abstract]   [Full Text] [Related]  

  • 38. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of Incobotulinum toxin-A for the treatment of masseter muscle hypertrophy in Asian Indian patients: A 2-year follow-up study.
    Shome D; Vadera S; Shiva Ram M; Kapoor R
    J Cosmet Dermatol; 2020 Aug; 19(8):1892-1899. PubMed ID: 32539203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.